Biogen Pharmachem Share Price Target 2022, 2023, 2024, 2025, 2030
Biogen Pharmachem Share Price Target 2022, 2023, 2024, 2025, 2030:- Biogen Pharmachem, formerly known as Sun Techno Overseas Ltd., is an India-based company. In 2011, the company changed its name from Wellworth Overseas Ltd. at Sun Techno Overseas Ltd.
So in this article we try to give Biogen Pharmachem a new path through technical and fundamental analysis.
Biogen Pharmachem Share Price Target 2022
The company is engaged in trading in shares and securities, retail brokerage and consulting. The company began trading and trading in commodities, both agricultural and precious metals, as well as other commodities in current and future markets. The company further diversifies its business activities in the energy sector by setting up wind farms.
Biogen Pharmachem’s stock price target will be available by the end of financial year 2022. Biogen Pharmachem’s initial price will be around Rs 1.40. And the second target budget price of Biogen Pharmachem will be Rs 1.50.
| Year | Biogen Pharmachem Share Price Target 2022 | Downside Target |
|---|---|---|
| First Target 2022 | Rs 1.40 | Rs 0.80 |
| Second Target 2022 | Rs 1.50 | Rs 0.75 |
Also read:- Bajaj Consumer Share Price Target 2022, 2023, 2024, 2025, 2030
Biogen Pharmachem Share Price Target 2023
Biogen Pharmachem Ltd. invests and trades in shares and securities. It trades commodities including agricultural and precious metals and other goods on current and future markets. The company also provides stock brokerage and consulting services. In addition, it generates trades and sells wind energy.
Biogen Pharmachem share price target by the end of 2023. The target value of Acrysil’s first shares for the financial year 2023 is estimated at Rs 1.80. And the second indicative price behind Biogen Pharmachem could offer around Rs 2.
| Year | Biogen Pharmachem Share Price Target 2023 | Downside Target |
|---|---|---|
| First Target 2023 | Rs 1.80 | Rs 0.70 |
| Second Target 2023 | Rs 2 | Rs 0.65 |
Also read:- JTL Infra Share Price Target 2022, 2023, 2024, 2025, 2030
Biogen Pharmachem Share Price Target 2024
The company has started trading operations and business in commodities both in agricultural as well as precious metals and other commodities in current and future markets. The company explored business opportunities in the field of import and export and trading of gold, silver and other precious metals including diamonds. The company further diversifies its business activities in the field of energy by building wind farms.
At this time, we try to predict the price of the two Biogen Pharmachem that will be available in 2024. The first target price of Biogen Pharmachem is Rs 2.30. And Biogen Pharmachem’s second target price could exceed Rs 2.50.
| Year | Biogen Pharmachem Share Price Target 2024 | Downside Target |
|---|---|---|
| First Target 2024 | Rs 2.30 | Rs 0.50 |
| Second Target 2024 | Rs 2.50 | Rs 0.40 |
Also read:- Avanti Feeds Share Price Target 2022, 2023, 2024, 2025, 2030
Biogen Pharmachem Share Price Target 2025
Biogen Pharmachem’s price-to-earnings ratio, which indicates for every rupee of earnings an investor is willing to pay for a share. As a general rule, stocks trading at a low P/E are undervalued. Biogen Pharmachem has a PE ratio of -8700, which is low and relatively undervalued. Biogen Pharmachem posted 0% revenue growth, which is weak relative to its growth and performance.
Biogen Pharmachem’s two share price targets for FY 2025. Biogen Pharmachem’s share price in FY 2025 will be Rs 2.90. And the second price target for Biogen Pharmachem for FY2025 will be around Rs 3.
| Year | Biogen Pharmachem Share Price Target 2025 | Downside Target |
|---|---|---|
| First Target 2025 | Rs 2.90 | Rs 0.40 |
| Second Target 2025 | Rs 3 | 0.30 |
Also read:- Meghmani Organics Share Price Target 2022, 2023, 2024, 2025, 2030
Biogen Pharmachem Share Price Target 2030
The inventory turnover ratio is an indicator of activity and is a tool for evaluating the liquidity of the company’s inventory. It measures how many times a company has sold and replaced its inventory over a period of time. Biogen Pharmachem has an inventory turnover ratio of 0, which indicates that management is ineffective in managing inventory and working capital.
Return on assets measures how efficiently a company can achieve a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Biogen Pharmachem has a ROA of -2.91%, which bodes poorly for future performance.
The target price for Biogen Pharmachem shares will be available by the end of financial year 2030. The price of the first share of Biogen Pharmachem will be Rs 8. And the second Biogen Pharmachem stock price target will be Rs 9. by the end of the financial year 2030.
| Year | Biogen Pharmachem Share Price Target 2030 | Downside Target |
|---|---|---|
| First Target 2030 | Rs 8 | Rs 0.20 |
| Second Target 2030 | Rs 9 | Rs 0.10 |
Also read:- NCC Share Price Target 2022, 2023, 2024, 2025, 2030
Future Prospectus of Biogen Pharmachem Share
- Biogen Pharmachem plans to expand its renewable energy portfolio by acquiring existing projects and is also looking for new opportunities in the transmission and distribution sectors.
- In the coming years, Biogen Pharmachem needs to open up and offer its customers and clients more options to do the right thing and continue to help the company make more money annually without distraction.
Biogen Pharmachem Share Price Target 2022, 2023, 2024, 2025, 2030 Table
| Year | Biogen Pharmachem Share Price Target | Downside Target |
|---|---|---|
| First Target 2022 | Rs 1.40 | Rs 0.80 |
| Second Target 2022 | Rs 1.50 | Rs 0.75 |
| First Target 2023 | Rs 1.80 | Rs 0.70 |
| Second Target 2023 | Rs 2 | Rs 0.65 |
| First Target 2024 | Rs 2.30 | Rs 0.50 |
| Second Target 2024 | Rs 2.50 | Rs 0.40 |
| First Target 2025 | Rs 2.90 | Rs 0.40 |
| Second Target 2025 | Rs 3 | Rs 0.30 |
| First Target 2030 | Rs 8 | Rs 0.20 |
| Second Target 2030 | Rs 9 | Rs 0.10 |
Risk of Biogen Pharmachem Share
- Biogen Pharmachem needs additional funding to realize its full potential across the industry, otherwise Biogen Pharmachem will not be able to deliver benefits or returns to its investors for years to come.
- Biogen Pharmachem has a very high debt to the company that needs to be reduced in the coming years or any sales or income they generate annually will be used to cover their debts.
Expert Views on Biogen Pharmachem Share
With all the features related to Biogen Pharmachem, we can say that you should watch this share for some time and I would say you need to wait some time before investing in Biogen Pharmachem shares.
F.A.Q. Biogen Pharmachem Share Price Target
– Where is the Headquarter of Biogen Pharmachem Located?
The Headquarter of Biogen Pharmachem Located in Rajkot, Gujarat.
– Who is the Present MD of Biogen Pharmachem?
The Present MD of Biogen Pharmachem is Akshay Makadiya.
– In which Business Biogen Pharmachem Involved?
Biogen Pharmachem trades in commodities, including agro based and precious metals, and other goods in present and future markets. The company also provides stock broking and consulting services. In addition, it generates, trades, and sells wind power.
I hope that after reading the article Biogen Pharmachem Share Price Target 2022, 2023, 2024, 2025, 2030 you must have got a good idea what kind of performance can be seen in the growth of the Company. If you still have any question related to this article in your mind, then do not forget to tell in the comment at all. Stay tuned to Market in India for important information about this type of stock in the stock market.
Also read:-
